Literature DB >> 20740331

Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.

Sawitree Chiampanichayakul1, Songyot Anuchapreeda, Nuttapol Chruewkamlow, Kodchakorn Mahasongkram, Pattra Thanaratanakorn, Watchara Kasinrerk.   

Abstract

Multidrug resistance (MDR) in leukemia is commonly associated with the expression of a transmembrane protein, P-glycoprotein (P-gp). In this study, two monoclonal antibodies (mAbs) specific for the extracellular domain of P-gp were generated. By employing the generated mAbs, a two-color lysed whole blood flow cytometric method for surface P-gp and an efficient sandwich ELISA for soluble P-gp determinations were established. By using the established methods, surface and soluble P-gp were detected in several leukemia patients. The presence of soluble P-gp could be used to identify the P-gp surface expression patients. Detection of soluble P-gp reported provides a new basis that may lead to a better understanding of the MDR mechanism in leukemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20740331     DOI: 10.1007/s12185-010-0668-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells.

Authors:  A Krishan; A Sauerteig; J H Stein
Journal:  Cytometry       Date:  1991

3.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

Review 4.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

5.  Application of flow cytometry immunophenotyping and multidrug resistance assay in B-cell acute lymphoid leukemia and multiple myeloma.

Authors:  K Jakab; L Gopcsa; E Adam; G Domjan; B Sarkadi; K Paloczi
Journal:  Neoplasma       Date:  2005       Impact factor: 2.575

6.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

7.  P-glycoprotein epitope mapping. II. The murine monoclonal antibody MM6.15 to human multidrug-resistant cells binds with three distinct loops in the MDR1-P-glycoprotein extracellular domain.

Authors:  M Cianfriglia; G Romagnoli; M Tombesi; F Poloni; G Falasca; F Di Modugno; M Castagna; A Chersi
Journal:  Int J Cancer       Date:  1995-03-29       Impact factor: 7.396

8.  Simple method for screening of alpha-thalassaemia 1 carriers.

Authors:  Chatchai Tayapiwatana; Surakit Kuntaruk; Thanusak Tatu; Sawitree Chiampanichayakul; Thongperm Munkongdee; Pranee Winichagoon; Suthat Fuchareon; Watchara Kasinrerk
Journal:  Int J Hematol       Date:  2009-05-14       Impact factor: 2.490

Review 9.  P-glycoprotein, multidrug resistance and tumor progression.

Authors:  G Bradley; V Ling
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

10.  Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft.

Authors:  L S Rittmann-Grauer; M A Yong; V Sanders; D G Mackensen
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

View more
  5 in total

1.  Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritis.

Authors:  E E Perez-Guerrero; L Gonzalez-Lopez; J F Muñoz-Valle; J C Vasquez-Jimenez; M Ramirez-Villafaña; E N Sanchez-Rodriguez; S R Gutierrez-Ureña; S Cerpa-Cruz; E A Aguilar-Chavez; E G Cardona-Muñoz; M L Vazquez-Villegas; A M Saldaña-Cruz; N A Rodriguez-Jimenez; N S Fajardo-Robledo; J I Gamez-Nava
Journal:  Inflammopharmacology       Date:  2018-09-12       Impact factor: 4.473

2.  Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus.

Authors:  Edsaul Emilio Perez-Guerrero; Jorge Ivan Gamez-Nava; Jose Francisco Muñoz-Valle; Ernesto German Cardona-Muñoz; David Bonilla-Lara; Nicte Selene Fajardo-Robledo; Arnulfo Hernan Nava-Zavala; Teresa Arcelia Garcia-Cobian; Ana Rosa Rincón-Sánchez; Jessica Daniela Murillo-Vazquez; David Cardona-Müller; Maria Luisa Vazquez-Villegas; Sylvia Elena Totsuka-Sutto; Laura Gonzalez-Lopez
Journal:  Clin Exp Med       Date:  2017-02-27       Impact factor: 5.057

3.  Steroid Resistance Associated with High MIF and P-gp Serum Levels in SLE Patients.

Authors:  Alberto Beltrán-Ramírez; José Francisco Muñoz-Valle; Jorge I Gamez-Nava; Ana Miriam Saldaña-Cruz; Laura Gonzalez-Lopez; Alejandro Padilla-Ortega; Francisco I Arias-García; Gabriela Athziri Sánchez-Zuno; Cesar Arturo Nava-Valdivia; Juan Manuel Ponce-Guarneros; Jesús Jonathan García-Galindo; Edsaúl Emilio Perez-Guerrero
Journal:  Molecules       Date:  2022-10-10       Impact factor: 4.927

4.  Characterization of human colorectal cancer MDR1/P-gp Fab antibody.

Authors:  Xuemei Zhang; Gary Guishan Xiao; Ying Gao
Journal:  ScientificWorldJournal       Date:  2013-11-07

5.  Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line.

Authors:  Aoranit Somno; Songyot Anuchapreeda; Nuttapol Chruewkamlow; Supansa Pata; Watchara Kasinrerk; Sawitree Chiampanichayakul
Journal:  Leuk Res Rep       Date:  2016-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.